News

Humanigen, PCI Pharma Services Enter Agreement for Lenzilumab Commercialization

June 17, 2022

Humanigen and PCI Pharma Servicesare partnering up for the commercialization of lenzilumab.

MHRA to Play Greater Role in International Medicines Regulation

June 17, 2022

MHRA has been accepted as a full member of three international work-sharing partnerships aimed at making sure medicines and medical devices are regulated safely and efficiently across the world.

Icosapent Ethyl Gains Nod from NICE

June 17, 2022

NICE has published its final draft guidance recommending the use of Vazkepa (icosapent ethyl) in adults to reduce heart attacks and strokes.

Merck Collaborates with Agilent Technologies on PAT for Downstream Processing

June 17, 2022

Merck has entered into a collaboration with Agilent Technologies with the aim of filling the industry gap in PAT for downstream processing.

Researchers Invent New Material that Can Capture and Release Biomolecules

June 17, 2022

A new polymer surface material has been invented by researchers in Sweden that uses electrical signals to both capture and release biomolecules.

Exothera, LogicBioTherapeutics, and Polyplus Collaborate on Industrial-Scale AAV Manufacturing

June 17, 2022

Exothera, LogicBioTherapeutics, and Polyplus-transfection, are collaborating on the development of a scalable AAV manufacturing platform.

CPHI China Opens its International Partnering Program After China Goes Up in CPHI Index

June 17, 2022

CPHI China and P-MEC China has opened its online partnering platform after China experienced gains in the CPHI Pharma Index.

Pain Regulation Gene Discovery Leads to New Treatment Target

June 17, 2022

UK researchers have discovered a gene involved in chronic pain, which has created a new treatment target.

FDA Publishes Draft Quality Risk Management Guidance

June 16, 2022

The draft ICH Q9(R1) document details the importance of quality risk management principles.

FDA Publishes Guidance on Regenerative Medicine Therapies

June 16, 2022

The new draft guidance describes a standards recognition program for regenerative medicine therapies.